Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Therapy - Methods and Clinical Development Année : 2023

Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth

Résumé

Virus-like particles (VLPs) are versatile protein-based platforms that can be used as a vaccine platform mainly in infectiology. In the present work, we compared a previously designed, non-infectious, adenovirus-inspired 60-mer dodecahedric VLP to display short epitopes or a large tumor model antigen. To validate these two kinds of platforms as a potential immuno-stimulating approach, we evaluated their ability to control melanoma B16-ovalbumin (OVA) growth in mice. A set of adjuvants was screened, showing that polyinosinic-polycytidylic acid (poly(I:C)) was well suited to generate a homogeneous cellular and humoral response against the desired epitopes. In a prophylactic setting, vaccination with the VLP displaying these epitopes resulted in total inhibition of tumor growth 1 month after vaccination. A therapeutic vaccination strategy showed a delay in grafted tumor growth or its total rejection. If the "simple" epitope display on the VLP is sufficient to prevent tumor growth, then an improved engineered platform enabling display of a large antigen is a tool to overcome the barrier of immune allele restriction, broadening the immune response, and paving the way for its potential utilization in humans as an off-the-shelf vaccine.
Fichier principal
Vignette du fichier
Besson et al. Molecular therapy.pdf (2.05 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03969612 , version 1 (26-10-2023)

Identifiants

Citer

Solène Besson, Emilie Boucher, David Laurin, Olivier Manches, Caroline Aspord, et al.. Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth. Molecular Therapy - Methods and Clinical Development, 2023, 28, pp.76-89. ⟨10.1016/j.omtm.2022.12.003⟩. ⟨hal-03969612⟩
831 Consultations
7 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More